In an in vitro chronic lymphocytic leukemia (CLL) study, culture with blinatumomab significantly increased the levels of IFN-γ, TNF-α, TNF-β and IL-8 (interleukin-8) [43]. The gene discussed is CXCL8; the disease is B-cell chronic lymphocytic leukemia.